Related Experiment Video
Updated: May 7, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis
Gregory J Keir1, Benjamin Garfield, David M Hansell
1Royal Brompton Hospital, , London, UK.
Abstract:
In sarcoidosis, chronic pulmonary aspergillosis (CPA) may be associated with significant morbidity, and treatment failure rates are often high, even with newer triazole antifungal agents. We report a treatment regimen of cyclical caspofungin infusions in 10 patients with sarcoidosis and worsening CPA despite oral triazoles.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Antifungal Agents
Fungal Phylum Ascomycota
Fungal Phylum Microsporidia
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...